Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
33
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kennedy Edward Moore Jr. | Director | 15 | $535.9K | $0 | 2026-06-24 |
| Morrison Briggs | Director | 28 | $590.5K | $2.77M | 2026-06-24 |
| Saik Andrew | Chief Financial Officer | 12 | $0 | $261.6K | 2026-06-24 |
| Smaldone Alsup Laurie | Director | 12 | $0 | $0 | 2026-06-24 |
| Bain Linda | Director | 11 | $0 | $0 | 2026-06-24 |
| Cunningham Everett | Director | 9 | $0 | $0 | 2026-06-24 |
| Norwalk Leslie V | Director | 12 | $0 | $0 | 2026-06-24 |
| Cacace Angela M | Chief Scientific Officer | 16 | $0 | $303.6K | 2026-06-17 |
| Teel Randy | President and CEO | 10 | $0 | $226.5K | 2026-05-21 |
| Loomis David K | VP, Chief Accounting Officer | 15 | $0 | $77.5K | 2026-05-11 |
| Berkowitz Noah | Chief Medical Officer | 12 | $0 | $323.8K | 2026-05-11 |
| Houston John G | President and CEO | 77 | $480.0K | $17.74M | 2026-02-27 |
| AGARWAL SUNIL | Director | 6 | $0 | $0 | 2025-06-25 |
| YOUNG JOHN D | Director | 7 | $0 | $0 | 2025-06-25 |
| Taylor Ian | Senior Vice President, Biology | 78 | $14.7K | $7.71M | 2025-02-24 |
| Peck Ronald | Chief Medical Officer | 37 | $0 | $5.12M | 2024-02-23 |
| Cassidy Sean A | Chief Financial Officer | 79 | $25.6K | $9.32M | 2024-02-23 |
| DIXON WENDY L | Director | 5 | $0 | $0 | 2023-06-15 |
| Margus Bradley Albert | Director | 18 | $640.0K | $6.52M | 2022-06-16 |
| Ratcliffe Liam | Director | 57 | $40.96M | $51.37M | 2022-06-16 |
| SHANNON TIMOTHY M | Director | 40 | $372.8K | $34.51M | 2022-06-16 |
| Canaan Partners IX LLC | 10% Owner | 2 | $0 | $0 | 2020-10-14 |
| Loven Jakob | Director | 5 | $5.00M | $0 | 2020-06-03 |
| PARMAR KUSH | Director | 3 | $0 | $0 | 2019-09-24 |
| 5AM VENTURES III, L.P. | 10% Owner | 8 | $0 | $0 | 2019-09-16 |
| Schwab Andrew J. | 10% Owner | 4 | $0 | $17.71M | 2019-06-28 |
| Canaan IX L.P. | 10% Owner | 5 | $0 | $0 | 2019-06-10 |
| 5AM Co-Investors III, L.P. | 10% Owner | 14 | $0 | $3.73M | 2019-06-07 |
| DIEKMAN JOHN D | 10% Owner | 2 | $0 | $5.11M | 2019-03-28 |
| Crew Andrew | See Remarks | 11 | $0 | $0 | 2019-03-01 |
| Flynn James E | 10% Owner | 9 | $5.00M | $0 | 2018-10-01 |
| RA CAPITAL MANAGEMENT, LLC | Other | 5 | $16.00M | $0 | 2018-10-01 |
| Crews Craig Martin | 10% Owner | 2 | $0 | $0 | 2018-09-26 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Bain Linda | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 22,714 | — | $0 | 22,714 | SEC↗ |
| Cunningham Everett | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 22,714 | — | $0 | 22,714 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 22,714 | — | $0 | 22,714 | SEC↗ |
| Morrison Briggs | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 22,714 | — | $0 | 22,714 | SEC↗ |
| Norwalk Leslie V | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 22,714 | — | $0 | 22,714 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award deriv | 2026-06-24 | 2026-06-26 | 22,714 | — | $0 | 22,714 | SEC↗ |
| Saik Andrew | Chief Financial Officer | S Sale | 2026-06-24 | 2026-06-24 | 5,696 | $8.16 | $46.5K | 187,432 | SEC↗ |
| Bain Linda | Director | A Award | 2026-06-24 | 2026-06-26 | 15,527 | — | $0 | 41,572 | SEC↗ |
| Cunningham Everett | Director | A Award | 2026-06-24 | 2026-06-26 | 15,527 | — | $0 | 41,572 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award | 2026-06-24 | 2026-06-26 | 15,527 | — | $0 | 54,957 | SEC↗ |
| Morrison Briggs | Director | A Award | 2026-06-24 | 2026-06-26 | 15,527 | — | $0 | 111,548 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2026-06-24 | 2026-06-26 | 15,527 | — | $0 | 41,572 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award | 2026-06-24 | 2026-06-26 | 15,527 | — | $0 | 41,572 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2026-06-17 | 2026-06-18 | 2,576 | $7.60 | $19.6K | 180,390 | SEC↗ |
| Teel Randy | President and CEO | S Sale | 2026-05-21 | 2026-05-22 | 2,209 | $9.04 | $20.0K | 285,009 | SEC↗ |
| Teel Randy | President and CEO | S Sale | 2026-05-11 | 2026-05-13 | 9,657 | $9.94 | $96.0K | 287,218 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | S Sale | 2026-05-11 | 2026-05-13 | 11,108 | $9.94 | $110.4K | 191,395 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2026-05-11 | 2026-05-13 | 9,657 | $9.94 | $96.0K | 182,966 | SEC↗ |
| Loomis David K | VP, Chief Accounting Officer | S Sale | 2026-05-11 | 2026-05-13 | 1,919 | $9.94 | $19.1K | 40,193 | SEC↗ |
| Saik Andrew | Chief Financial Officer | S Sale | 2026-05-11 | 2026-05-13 | 11,139 | $9.94 | $110.7K | 193,128 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | S Sale | 2026-03-18 | 2026-03-19 | 6,435 | $11.10 | $71.4K | 202,503 | SEC↗ |
| Morrison Briggs | Director | P Buy | 2026-03-06 | 2026-03-09 | 20,000 | $13.40 | $268.0K | 96,021 | SEC↗ |
| Houston John G | Director | S Sale | 2026-02-27 | 2026-03-02 | 11,787 | $13.14 | $154.9K | 1,122,183 | SEC↗ |
| Houston John G | Director | S Sale | 2026-02-27 | 2026-03-02 | 18,822 | $13.24 | $249.2K | 1,133,970 | SEC↗ |
| Houston John G | Director | S Sale | 2026-02-27 | 2026-03-02 | 4,688 | $13.24 | $62.1K | 1,152,792 | SEC↗ |
| Teel Randy | President and CEO | A Award deriv | 2026-02-26 | 2026-03-02 | 218,691 | — | $0 | 218,691 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Loomis David K | VP, Chief Accounting Officer | A Award deriv | 2026-02-26 | 2026-03-02 | 18,504 | — | $0 | 18,504 | SEC↗ |
| Teel Randy | President and CEO | A Award | 2026-02-26 | 2026-03-02 | 147,791 | — | $0 | 297,487 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award | 2026-02-26 | 2026-03-02 | 45,000 | — | $0 | 204,267 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award | 2026-02-26 | 2026-03-02 | 45,000 | — | $0 | 208,938 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award | 2026-02-26 | 2026-03-02 | 45,000 | — | $0 | 192,623 | SEC↗ |
| Loomis David K | VP, Chief Accounting Officer | A Award | 2026-02-26 | 2026-03-02 | 12,420 | — | $0 | 42,112 | SEC↗ |
| Teel Randy | President and CEO | A Award | 2026-02-26 | 2026-03-12 | 147,179 | — | $0 | 296,875 | SEC↗ |
| Teel Randy | President and CEO | S Sale | 2026-02-23 | 2026-02-25 | 3,748 | $12.16 | $45.6K | 149,696 | SEC↗ |
| Teel Randy | President and CEO | S Sale | 2026-02-23 | 2026-02-25 | 1,038 | $12.16 | $12.6K | 153,444 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2026-02-23 | 2026-02-25 | 1,038 | $12.16 | $12.6K | 150,194 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2026-02-23 | 2026-02-25 | 2,571 | $12.16 | $31.3K | 147,623 | SEC↗ |
| Loomis David K | Chief Accounting Officer | S Sale | 2026-02-23 | 2026-02-25 | 1,108 | $12.16 | $13.5K | 29,692 | SEC↗ |
| Loomis David K | Chief Accounting Officer | S Sale | 2026-02-13 | 2026-02-18 | 1,016 | $11.89 | $12.1K | 30,800 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | S Sale | 2026-02-13 | 2026-02-18 | 5,685 | $11.89 | $67.6K | 163,938 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2026-02-13 | 2026-02-18 | 4,592 | $11.89 | $54.6K | 151,232 | SEC↗ |
| Saik Andrew | Chief Financial Officer | S Sale | 2026-02-13 | 2026-02-18 | 5,134 | $11.89 | $61.0K | 159,267 | SEC↗ |
| Teel Randy | President and CEO | S Sale | 2026-02-13 | 2026-02-18 | 4,403 | $11.89 | $52.4K | 154,482 | SEC↗ |
| Loomis David K | Chief Accounting Officer | S Sale | 2025-11-07 | 2025-11-07 | 230 | $9.89 | $2.3K | 31,697 | SEC↗ |
| Morrison Briggs | Director | P Buy | 2025-09-22 | 2025-09-24 | 30,000 | $7.57 | $227.1K | 76,021 | SEC↗ |
| Norwalk Leslie V | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| Cunningham Everett | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| Bain Linda | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| YOUNG JOHN D | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| Morrison Briggs | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 23,105 | — | $0 | 23,105 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2025-06-25 | 2025-06-30 | 23,105 | — | $0 | 23,105 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 26,045 | SEC↗ |
| Cunningham Everett | Director | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 26,045 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 39,430 | SEC↗ |
| Bain Linda | Director | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 26,045 | SEC↗ |
| YOUNG JOHN D | Director | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 26,045 | SEC↗ |
| Morrison Briggs | Director | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 46,021 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award | 2025-06-25 | 2025-06-27 | 16,025 | — | $0 | 26,045 | SEC↗ |
| AGARWAL SUNIL | Director | A Award | 2025-06-25 | 2025-06-30 | 16,025 | — | $0 | 30,166 | SEC↗ |
| Saik Andrew | Chief Financial Officer | S Sale | 2025-06-24 | 2025-06-24 | 5,700 | $7.61 | $43.4K | 164,401 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2025-06-17 | 2025-06-18 | 2,583 | $7.49 | $19.3K | 154,248 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award deriv | 2025-05-09 | 2025-05-13 | 91,000 | — | $0 | 91,000 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award deriv | 2025-05-09 | 2025-05-13 | 91,000 | — | $0 | 91,000 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award deriv | 2025-05-09 | 2025-05-13 | 91,000 | — | $0 | 91,000 | SEC↗ |
| Loomis David K | Chief Accounting Officer | A Award deriv | 2025-05-09 | 2025-05-13 | 18,100 | — | $0 | 18,100 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award | 2025-05-09 | 2025-05-13 | 59,600 | — | $0 | 169,623 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award | 2025-05-09 | 2025-05-13 | 59,600 | — | $0 | 156,831 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award | 2025-05-09 | 2025-05-13 | 59,600 | — | $0 | 170,101 | SEC↗ |
| Loomis David K | Chief Accounting Officer | A Award | 2025-05-09 | 2025-05-13 | 11,825 | — | $0 | 30,688 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | S Sale | 2025-03-18 | 2025-03-19 | 8,658 | $8.59 | $74.4K | 110,023 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2025-02-24 | 2025-02-25 | 5,154 | $16.55 | $85.3K | 1,157,480 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2025-02-24 | 2025-02-25 | 26,184 | $16.75 | $438.6K | 1,162,634 | SEC↗ |
| Taylor Ian | President, R&D | S Sale | 2025-02-24 | 2025-02-25 | 7,356 | $16.75 | $123.2K | 160,785 | SEC↗ |
| Taylor Ian | President, R&D | S Sale | 2025-02-24 | 2025-02-25 | 1,664 | $16.55 | $27.5K | 159,121 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2025-02-24 | 2025-02-25 | 3,061 | $16.75 | $51.3K | 98,377 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | S Sale | 2025-02-24 | 2025-02-25 | 1,146 | $16.55 | $19.0K | 97,231 | SEC↗ |
| Loomis David K | Chief Accounting Officer | S Sale | 2025-02-24 | 2025-02-25 | 1,214 | $16.75 | $20.3K | 18,863 | SEC↗ |
| Houston John G | President and CEO | A Award deriv | 2025-02-13 | 2025-02-18 | 232,000 | — | $0 | 232,000 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award deriv | 2025-02-13 | 2025-02-18 | 74,960 | — | $0 | 74,960 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award deriv | 2025-02-13 | 2025-02-18 | 84,330 | — | $0 | 84,330 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | A Award deriv | 2025-02-13 | 2025-02-18 | 31,483 | — | $0 | 31,483 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award deriv | 2025-02-13 | 2025-02-18 | 74,960 | — | $0 | 74,960 | SEC↗ |
| Loomis David K | Chief Accounting Officer | A Award deriv | 2025-02-13 | 2025-02-18 | 16,176 | — | $0 | 16,176 | SEC↗ |
| Houston John G | President and CEO | A Award | 2025-02-13 | 2025-02-18 | 152,000 | — | $0 | 1,188,681 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award | 2025-02-13 | 2025-02-18 | 49,092 | — | $0 | 100,944 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award | 2025-02-13 | 2025-02-18 | 55,229 | — | $0 | 118,681 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | A Award | 2025-02-13 | 2025-02-18 | 20,619 | — | $0 | 168,141 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award | 2025-02-13 | 2025-02-18 | 49,092 | — | $0 | 110,501 | SEC↗ |
| Loomis David K | Chief Accounting Officer | A Award | 2025-02-13 | 2025-02-18 | 10,584 | — | $0 | 18,624 | SEC↗ |
| Loomis David K | Chief Accounting Officer | S Sale | 2024-11-07 | 2024-11-12 | 231 | $27.69 | $6.4K | 8,040 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award deriv | 2024-06-24 | 2024-06-26 | 94,418 | — | $0 | 94,418 | SEC↗ |
| Saik Andrew | Chief Financial Officer | A Award | 2024-06-24 | 2024-06-26 | 61,409 | — | $0 | 61,409 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award deriv | 2024-06-17 | 2024-06-18 | 24,632 | — | $0 | 24,632 | SEC↗ |
| Cacace Angela M | Chief Scientific Officer | A Award | 2024-06-17 | 2024-06-18 | 15,995 | — | $0 | 51,852 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| Norwalk Leslie V | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| YOUNG JOHN D | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| Morrison Briggs | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| Cunningham Everett | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| Bain Linda | Director | A Award deriv | 2024-05-29 | 2024-05-31 | 9,070 | — | $0 | 9,070 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 10,020 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 10,020 | SEC↗ |
| YOUNG JOHN D | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 10,020 | SEC↗ |
| Morrison Briggs | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 29,996 | SEC↗ |
| AGARWAL SUNIL | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 14,141 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 23,405 | SEC↗ |
| Cunningham Everett | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 10,020 | SEC↗ |
| Bain Linda | Director | A Award | 2024-05-29 | 2024-05-31 | 5,899 | — | $0 | 10,020 | SEC↗ |
| Teel Randy | Int. Chief Financial Officer | A Award deriv | 2024-05-21 | 2024-05-23 | 19,675 | — | $0 | 19,675 | SEC↗ |
| Teel Randy | Int. Chief Financial Officer | A Award | 2024-05-21 | 2024-05-23 | 13,300 | — | $0 | 59,341 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award deriv | 2024-03-18 | 2024-03-21 | 93,879 | — | $0 | 93,879 | SEC↗ |
| Berkowitz Noah | Chief Medical Officer | A Award | 2024-03-18 | 2024-03-21 | 63,452 | — | $0 | 63,452 | SEC↗ |
| Loomis David K | Chief Accounting Officer | A Award deriv | 2024-02-23 | 2024-02-27 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | A Award deriv | 2024-02-23 | 2024-02-27 | 58,100 | — | $0 | 58,100 | SEC↗ |
| Peck Ronald | Chief Medical Officer | A Award deriv | 2024-02-23 | 2024-02-27 | 58,100 | — | $0 | 58,100 | SEC↗ |
| Houston John G | President and CEO | A Award deriv | 2024-02-23 | 2024-02-27 | 184,200 | — | $0 | 184,200 | SEC↗ |
| Loomis David K | Chief Accounting Officer | A Award | 2024-02-23 | 2024-02-27 | 5,750 | — | $0 | 8,500 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2024-02-23 | 2024-02-27 | 1,701 | $47.05 | $80.0K | 147,522 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | A Award | 2024-02-23 | 2024-02-27 | 39,250 | — | $0 | 149,223 | SEC↗ |
| Peck Ronald | Chief Medical Officer | S Sale | 2024-02-23 | 2024-02-27 | 1,699 | $47.05 | $79.9K | 67,516 | SEC↗ |
| Peck Ronald | Chief Medical Officer | A Award | 2024-02-23 | 2024-02-27 | 39,250 | — | $0 | 69,215 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | S Sale | 2024-02-23 | 2024-02-27 | 1,702 | $47.05 | $80.1K | 181,916 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2024-02-23 | 2024-02-27 | 5,196 | $47.05 | $244.5K | 1,036,681 | SEC↗ |
| Houston John G | President and CEO | A Award | 2024-02-23 | 2024-02-27 | 124,450 | — | $0 | 1,041,877 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2024-01-04 | 2024-01-08 | 0 | — | $0 | 10,519 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2024-01-04 | 2024-01-08 | 0 | — | $0 | 2,065 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise | 2024-01-04 | 2024-01-08 | 8,252 | $16.00 | $132.0K | 109,973 | SEC↗ |
| Loomis David K | Chief Accounting Officer | S Sale | 2023-11-08 | 2024-11-12 | 229 | $17.05 | $3.9K | 8,271 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise deriv | 2023-08-11 | 2023-08-14 | 4,010 | — | $0 | 0 | SEC↗ |
| Peck Ronald | Chief Medical Officer | S Sale | 2023-08-11 | 2023-08-14 | 1,324 | $24.39 | $32.3K | 29,965 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise | 2023-08-11 | 2023-08-14 | 4,010 | — | $0 | 31,289 | SEC↗ |
| AGARWAL SUNIL | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 24,948 | — | $0 | 24,948 | SEC↗ |
| Bain Linda | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| Cunningham Everett | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| DIXON WENDY L | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| Morrison Briggs | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| Norwalk Leslie V | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| YOUNG JOHN D | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 12,787 | — | $0 | 12,787 | SEC↗ |
| AGARWAL SUNIL | Director | A Award | 2023-06-15 | 2023-06-20 | 8,242 | — | $0 | 8,242 | SEC↗ |
| Bain Linda | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 4,121 | SEC↗ |
| Cunningham Everett | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 4,121 | SEC↗ |
| DIXON WENDY L | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 9,121 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 17,506 | SEC↗ |
| Morrison Briggs | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 24,097 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 4,121 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 4,121 | SEC↗ |
| YOUNG JOHN D | Director | A Award | 2023-06-15 | 2023-06-20 | 4,121 | — | $0 | 4,121 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise deriv | 2023-03-01 | 2023-03-03 | 4,791 | — | $0 | 0 | SEC↗ |
| Houston John G | President and CEO | M Exercise deriv | 2023-03-01 | 2023-03-03 | 17,510 | — | $0 | 0 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2023-03-01 | 2023-03-03 | 2,685 | — | $0 | 0 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise | 2023-03-01 | 2023-03-03 | 4,791 | — | $0 | 185,363 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | S Sale | 2023-03-01 | 2023-03-03 | 1,745 | $29.53 | $51.5K | 183,618 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2023-03-01 | 2023-03-03 | 5,878 | $29.53 | $173.6K | 917,427 | SEC↗ |
| Houston John G | President and CEO | M Exercise | 2023-03-01 | 2023-03-03 | 17,510 | — | $0 | 923,305 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2023-03-01 | 2023-03-03 | 1,051 | $29.53 | $31.0K | 101,721 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise | 2023-03-01 | 2023-03-03 | 2,685 | — | $0 | 102,772 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | A Award deriv | 2023-02-22 | 2023-02-24 | 57,450 | — | $0 | 57,450 | SEC↗ |
| Houston John G | President and CEO | A Award deriv | 2023-02-22 | 2023-02-24 | 186,250 | — | $0 | 186,250 | SEC↗ |
| Peck Ronald | Chief Medical Officer | A Award deriv | 2023-02-22 | 2023-02-24 | 57,450 | — | $0 | 57,450 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | A Award deriv | 2023-02-22 | 2023-02-24 | 57,450 | — | $0 | 57,450 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | A Award | 2023-02-22 | 2023-02-24 | 19,125 | — | $0 | 100,087 | SEC↗ |
| Houston John G | President and CEO | A Award | 2023-02-22 | 2023-02-24 | 61,975 | — | $0 | 905,795 | SEC↗ |
| Peck Ronald | Chief Medical Officer | A Award | 2023-02-22 | 2023-02-24 | 19,125 | — | $0 | 27,279 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | A Award | 2023-02-22 | 2023-02-24 | 19,125 | — | $0 | 180,572 | SEC↗ |
| Cunningham Everett | Director | A Award deriv | 2022-12-15 | 2022-12-19 | 30,095 | — | $0 | 30,095 | SEC↗ |
| YOUNG JOHN D | Director | A Award deriv | 2022-08-18 | 2022-08-22 | 24,572 | — | $0 | 24,572 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise deriv | 2022-08-12 | 2022-08-16 | 4,010 | — | $0 | 4,010 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise deriv | 2022-08-12 | 2022-08-16 | 4,010 | — | $0 | 4,010 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise | 2022-08-12 | 2022-08-16 | 4,010 | — | $0 | 9,412 | SEC↗ |
| Peck Ronald | Chief Medical Officer | S Sale | 2022-08-12 | 2022-08-16 | 1,258 | $68.99 | $86.8K | 8,154 | SEC↗ |
| Peck Ronald | Chief Medical Officer | S Sale | 2022-08-12 | 2022-08-16 | 1,258 | $54.84 | $69.0K | 8,154 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise | 2022-08-12 | 2022-08-16 | 4,010 | — | $0 | 9,412 | SEC↗ |
| Norwalk Leslie V | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| Morrison Briggs | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| Margus Bradley Albert | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| Bain Linda | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| Smaldone Alsup Laurie | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| Kennedy Edward Moore Jr. | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| Ratcliffe Liam | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| SHANNON TIMOTHY M | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| DIXON WENDY L | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 10,192 | — | $0 | 10,192 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2022-04-14 | 2022-04-18 | 16,188 | — | $0 | 494 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2022-04-14 | 2022-04-18 | 10,754 | $67.03 | $720.8K | 19,976 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2022-04-14 | 2022-04-18 | 7,104 | $66.07 | $469.4K | 30,730 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2022-04-14 | 2022-04-18 | 16,188 | $16.00 | $259.0K | 40,936 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2022-04-14 | 2022-04-18 | 3,102 | $65.24 | $202.4K | 37,834 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | G Gift | 2022-03-31 | 2022-04-01 | 3,000 | — | $0 | 80,962 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise deriv | 2022-03-11 | 2022-03-15 | 15,000 | $16.00 | $240.0K | 16,710 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | S Sale | 2022-03-11 | 2022-03-15 | 15,000 | $70.00 | $1.05M | 161,447 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise | 2022-03-11 | 2022-03-15 | 15,000 | $16.00 | $240.0K | 176,447 | SEC↗ |
| Houston John G | President and CEO | M Exercise deriv | 2022-03-04 | 2022-03-04 | 17,511 | — | $0 | 17,510 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise deriv | 2022-03-04 | 2022-03-04 | 4,791 | — | $0 | 4,791 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2022-03-04 | 2022-03-04 | 2,686 | — | $0 | 2,685 | SEC↗ |
| Houston John G | President and CEO | M Exercise | 2022-03-04 | 2022-03-04 | 17,511 | — | $0 | 849,844 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2022-03-04 | 2022-03-04 | 6,024 | $63.94 | $385.2K | 843,820 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise | 2022-03-04 | 2022-03-04 | 4,791 | — | $0 | 163,040 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | S Sale | 2022-03-04 | 2022-03-04 | 1,593 | $63.94 | $101.9K | 161,447 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise | 2022-03-04 | 2022-03-04 | 2,686 | — | $0 | 84,831 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2022-03-04 | 2022-03-04 | 869 | $63.94 | $55.6K | 83,962 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2022-03-01 | 2022-03-03 | 596 | — | $0 | 0 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2022-03-01 | 2022-03-03 | 925 | — | $0 | 13,872 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2022-03-01 | 2022-03-03 | 1,979 | — | $0 | 6,964 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise | 2022-03-01 | 2022-03-03 | 3,500 | $16.00 | $56.0K | 82,145 | SEC↗ |
| Houston John G | President and CEO | A Award deriv | 2022-02-23 | 2022-03-04 | 200,500 | — | $0 | 200,500 | SEC↗ |
| Peck Ronald | Chief Medical Officer | A Award deriv | 2022-02-23 | 2022-03-04 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | A Award deriv | 2022-02-23 | 2022-03-04 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | A Award deriv | 2022-02-23 | 2022-03-04 | 67,000 | — | $0 | 67,000 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2022-02-15 | 2022-02-17 | 20,000 | $19.36 | $387.2K | 37,633 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2022-02-15 | 2022-02-17 | 3,841 | $74.64 | $286.7K | 79,045 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise | 2022-02-15 | 2022-02-17 | 20,000 | $19.36 | $387.2K | 98,645 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2022-02-15 | 2022-02-17 | 5,867 | $71.74 | $420.9K | 92,778 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2022-02-15 | 2022-02-17 | 100 | $76.58 | $7.7K | 78,645 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2022-02-15 | 2022-02-17 | 300 | $75.80 | $22.7K | 78,745 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2022-02-15 | 2022-02-17 | 4,126 | $73.68 | $304.0K | 82,886 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2022-02-15 | 2022-02-17 | 5,766 | $72.55 | $418.3K | 87,012 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2022-01-14 | 2022-01-19 | 16,188 | — | $0 | 16,682 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2022-01-14 | 2022-01-19 | 5,100 | $67.28 | $343.1K | 26,856 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2022-01-14 | 2022-01-19 | 16,188 | $16.00 | $259.0K | 45,708 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2022-01-14 | 2022-01-19 | 9,919 | $64.33 | $638.1K | 35,789 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2022-01-14 | 2022-01-19 | 2,108 | $67.69 | $142.7K | 24,748 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2022-01-14 | 2022-01-19 | 3,833 | $65.24 | $250.1K | 31,956 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise deriv | 2021-12-30 | 2022-01-04 | 14,375 | — | $0 | 40,625 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise deriv | 2021-12-30 | 2022-01-04 | 5,625 | — | $0 | 46,559 | SEC↗ |
| Peck Ronald | Chief Medical Officer | S Sale | 2021-12-30 | 2022-01-04 | 8,629 | $80.96 | $698.6K | 5,402 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise | 2021-12-30 | 2022-01-04 | 14,375 | $47.38 | $681.1K | 19,777 | SEC↗ |
| Peck Ronald | Chief Medical Officer | M Exercise | 2021-12-30 | 2022-01-04 | 5,625 | $26.58 | $149.5K | 25,402 | SEC↗ |
| Peck Ronald | Chief Medical Officer | S Sale | 2021-12-30 | 2022-01-04 | 11,371 | $80.35 | $913.7K | 14,031 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise deriv | 2021-12-17 | 2021-12-21 | 15,000 | — | $0 | 14,384 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | S Sale | 2021-12-17 | 2021-12-21 | 15,000 | $70.00 | $1.05M | 158,249 | SEC↗ |
| Cassidy Sean A | Chief Financial Officer | M Exercise | 2021-12-17 | 2021-12-21 | 15,000 | $16.00 | $240.0K | 173,249 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-16 | 2021-12-16 | 37,206 | $68.97 | $2.57M | 185,686 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-16 | 2021-12-16 | 48,499 | $69.66 | $3.38M | 222,892 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-15 | 2021-12-16 | 67,549 | $66.50 | $4.49M | 277,086 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-15 | 2021-12-16 | 40,292 | $67.46 | $2.72M | 344,635 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-15 | 2021-12-16 | 5,695 | $65.74 | $374.4K | 271,391 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-14 | 2021-12-16 | 700 | $64.20 | $44.9K | 384,927 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-14 | 2021-12-16 | 36,308 | $65.38 | $2.37M | 385,627 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-12-14 | 2021-12-16 | 119,456 | $66.01 | $7.89M | 421,935 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2021-11-15 | 2021-11-17 | 12,206 | — | $0 | 8,943 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise deriv | 2021-11-15 | 2021-11-17 | 7,794 | — | $0 | 57,633 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-15 | 2021-11-15 | 3,532 | $83.90 | $296.3K | 541,391 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-15 | 2021-11-15 | 17,752 | $85.07 | $1.51M | 544,923 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2021-11-15 | 2021-11-17 | 6,856 | $83.07 | $569.5K | 91,789 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2021-11-15 | 2021-11-17 | 6,660 | $84.14 | $560.4K | 85,129 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | S Sale | 2021-11-15 | 2021-11-17 | 6,484 | $84.95 | $550.8K | 78,645 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise | 2021-11-15 | 2021-11-17 | 7,794 | $19.36 | $150.9K | 98,645 | SEC↗ |
| Taylor Ian | Chief Scientific Officer | M Exercise | 2021-11-15 | 2021-11-17 | 12,206 | $16.00 | $195.3K | 90,851 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-12 | 2021-11-15 | 12,760 | $84.02 | $1.07M | 562,675 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-12 | 2021-11-15 | 9,660 | $84.31 | $814.4K | 575,435 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-12 | 2021-11-15 | 17,449 | $85.96 | $1.50M | 585,095 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-11 | 2021-11-15 | 18,007 | $86.38 | $1.56M | 638,754 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-11 | 2021-11-15 | 5,582 | $87.71 | $489.6K | 656,761 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-11 | 2021-11-15 | 36,210 | $85.92 | $3.11M | 602,544 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-10 | 2021-11-15 | 1,498 | $89.16 | $133.6K | 672,351 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-10 | 2021-11-15 | 199 | $86.59 | $17.2K | 662,343 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-10 | 2021-11-15 | 3,956 | $87.11 | $344.6K | 662,542 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-10 | 2021-11-15 | 5,853 | $88.12 | $515.8K | 666,498 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-10 | 2021-11-15 | 1,852 | $90.18 | $167.0K | 673,849 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-09 | 2021-11-09 | 5,131 | $92.73 | $475.8K | 703,578 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-09 | 2021-11-09 | 580 | $91.33 | $53.0K | 675,701 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-09 | 2021-11-09 | 27,297 | $91.85 | $2.51M | 676,281 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-08 | 2021-11-09 | 54,568 | $94.93 | $5.18M | 735,195 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-08 | 2021-11-09 | 11,668 | $94.20 | $1.10M | 723,527 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-08 | 2021-11-09 | 11,130 | $93.03 | $1.04M | 712,397 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-08 | 2021-11-09 | 3,688 | $92.48 | $341.1K | 708,709 | SEC↗ |
| Ratcliffe Liam | Director | M Exercise deriv | 2021-11-05 | 2021-11-09 | 6,423 | — | $0 | 0 | SEC↗ |
| Ratcliffe Liam | Director | M Exercise deriv | 2021-11-05 | 2021-11-09 | 12,000 | — | $0 | 0 | SEC↗ |
| Ratcliffe Liam | Director | M Exercise | 2021-11-05 | 2021-11-09 | 12,000 | $33.57 | $402.8K | 24,923 | SEC↗ |
| Ratcliffe Liam | Director | M Exercise | 2021-11-05 | 2021-11-09 | 6,423 | $22.06 | $141.7K | 12,923 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 6,423 | $91.50 | $587.7K | 18,500 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 7,060 | $91.50 | $646.0K | 11,440 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 4,940 | $90.75 | $448.3K | 6,500 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 5,221 | $91.59 | $478.2K | 1,279 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 795 | $90.29 | $71.8K | 484 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 484 | $89.65 | $43.4K | 0 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 4,519 | $94.08 | $425.1K | 818,338 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 1,825 | $93.03 | $169.8K | 816,513 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 15,327 | $91.81 | $1.41M | 801,186 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 8,676 | $91.09 | $790.3K | 792,510 | SEC↗ |
| Ratcliffe Liam | Director | S Sale | 2021-11-05 | 2021-11-09 | 2,747 | $89.86 | $246.8K | 789,763 | SEC↗ |
| Houston John G | President and CEO | M Exercise deriv | 2021-11-01 | 2021-11-03 | 40,000 | — | $0 | 0 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2021-11-01 | 2021-11-03 | 15,918 | $87.98 | $1.40M | 847,902 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2021-11-01 | 2021-11-03 | 15,569 | $88.86 | $1.38M | 832,333 | SEC↗ |
| Houston John G | President and CEO | M Exercise | 2021-11-01 | 2021-11-03 | 40,000 | $16.00 | $640.0K | 872,333 | SEC↗ |
| Houston John G | President and CEO | S Sale | 2021-11-01 | 2021-11-03 | 8,513 | $87.13 | $741.7K | 863,820 | SEC↗ |
| SHANNON TIMOTHY M | Director | S Sale | 2021-09-07 | 2021-09-27 | 14,751 | $87.98 | $1.30M | 1,674,788 | SEC↗ |
| SHANNON TIMOTHY M | Director | S Sale | 2021-09-07 | 2021-09-27 | 2,030 | $90.75 | $184.2K | 1,653,128 | SEC↗ |
| SHANNON TIMOTHY M | Director | S Sale | 2021-09-07 | 2021-09-27 | 14,163 | $90.08 | $1.28M | 1,655,158 | SEC↗ |
| SHANNON TIMOTHY M | Director | S Sale | 2021-09-07 | 2021-09-27 | 5,467 | $88.90 | $486.0K | 1,669,321 | SEC↗ |
| SHANNON TIMOTHY M | Director | S Sale | 2021-09-03 | 2021-09-27 | 30,068 | $85.47 | $2.57M | 1,691,858 | SEC↗ |
| SHANNON TIMOTHY M | Director | S Sale | 2021-09-03 | 2021-09-27 | 2,319 | $86.39 | $200.3K | 1,689,539 | SEC↗ |